Journal Article

Quantitation of <i>N</i>′-Nitrosonornicotine (NNN) in Smokers' Urine by Liquid Chromatography-Tandem Mass Spectrometry

Michael Urban, Gerhard Scherer, Dominique Kavvadias, Heinz-Werner Hagedorn, Shixia Feng, Richard Serafin, Sunil Kapur, Raheema Muhammad, Yan Jin, Paul Mendes and Hans Roethig

in Journal of Analytical Toxicology

Volume 33, issue 5, pages 260-265
Published in print June 2009 | ISSN: 0146-4760
Published online June 2009 | e-ISSN: 1945-2403 | DOI:
Quantitation of N′-Nitrosonornicotine (NNN) in Smokers' Urine by Liquid Chromatography-Tandem Mass Spectrometry

More Like This

Show all results sharing these subjects:

  • Medical Toxicology
  • Toxicology (Non-medical)


Show Summary Details


The tobacco-specific nitrosamine N′-nitrosonornicotine (NNN) is carcinogenic to humans (IARC Group 1). Assessing the tobacco smoke-related exposure to NNN by suitable biomarkers is of interest for risk evaluation. Recently, NNN and NNN-N-glucuronide have been quantified in urine of smokers. However, it is unknown what percentage of the absorbed dose of NNN is excreted as total NNN (sum of free and conjugated NNN) in urine of smokers. We developed a sensitive method based on liquid chromatography with tandem mass spectrometry with deuterium-labeled internal standard for the determination of total NNN in human urine. The limit of quantitation of the method was 2 pg/mL with a calibration line linear up to 256 pg/mL. In a study with 16 smokers in which the respiratory retention of NNN was measured through controlled smoking, we found that on average about 1% of the pulmonary NNN dose was excreted in 24 h urine as total NNN.

Journal Article.  0 words. 

Subjects: Medical Toxicology ; Toxicology (Non-medical)

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.